CAJ | 학술논문

目的评价疾病家庭负担量表(family burden scale of diseases,FBS)应用于晚期血吸虫病(晚血)的信度和效度,为晚血家庭负担评价工具的选择提供科学依据.方法在湖南省汉寿县及湖北省江陵县,以FBS作为测评工具对晚血患者家属进行入户调查,评价其应用于晚血的信度和效度.结果共调查家属318名,FBS用于晚血家庭负担评价具有良好的分半信度(分半信度系数为0.93)、内部一致性(各维度Cronbach α系数范围为0.69-0.75)、集合效度(集合效度试验成功率为100%)和区分效度(区分效度试验成功率为97.22%).除家庭成员身体健康及心理健康2个维度得分地板效应分别达60.06%和47.17%外,其余维度地板效应均低于27%,各维度均未出现天花板效应.结论 FBS适用于晚血家庭负担评价,但尚需根据实际情况对部分条目进行完善.
목적 평개질병가정부담량표(family burden scale of diseases,FBS)응용우만기혈흡충병(만혈)적신도화효도,위만혈가정부담평개공구적선택제공과학의거.방법 재호남성한수현급호북성강릉현,이FBS작위측평공구대만혈환자가속진행입호조사,평개기응용우만혈적신도화효도.결과공조사가속318명,FBS용우만혈가정부담평개구유량호적분반신도(분반신도계수위0.93)、내부일치성(각유도Cronbach α계수범위위0.69-0.75)、집합효도(집합효도시험성공솔위100%)화구분효도(구분효도시험성공솔위97.22%).제가정성원신체건강급심리건강2개유도득분지판효응분별체60.06%화47.17%외,기여유도지판효응균저우27%,각유도균미출현천화판효응.결론 FBS괄용우만혈가정부담평개,단상수근거실제정황대부분조목진행완선.
Objective To evaluate the reliability and validity of family burden scale of diseases (FBS)in advanced schistosomiasis, so as to provide scientific basis for the selection of suitable tools for the measurement of family burden of the disease. Methods The family burden of patients with advanced schistosomiasis was estimated by interviewing their family members with FBS in Hanshou County of Hunan Province and Jiangling County of Hubei Province, and the reliability and validity of the scale were evaluated. Results A total of 318 family members were interviewed. The split-half reliability (with a split-half coefficient of 0.93)and the internal consistency (Cronbach α coefficients of the 6 dimensions ranged from 0. 69 to 0. 75)were satisfying; the convergent and discriminative validity were high with the test success rates of 100% and 97.22%,respectively. The percentages of floor effect and ceiling effect in most dimensions were not significant except in 2 dimensions namely physical health and mental health of family members (with the percentages of floor effect of 60.06% and 47.17%, respectively). Conclusion FBS is appropriate for estimating family burden of patients with advanced schistosomiasis, but some items need to be improved according to the specific conditions of the disease.